University of Birmingham identifies target to reduce GVHD risk
University of Birmingham researchers have identified CD70 as a key target to reduce the risk of GVHD in blood cancer patients.
University of Birmingham researchers have identified CD70 as a key target to reduce the risk of GVHD in blood cancer patients.
What's Your Reaction?
